Investigation of dopamine system genes in obsessive-compulsive disorder

Psychiatric Genetics

Volumn 8, Issue 3, 1998, Pages 163-169

  Billett, E A ^a   Richter, M A ^a   Sam, F ^a   Swinson, R P ^a   Dai, X Y ^a   King, N ^a   Badri, F ^a   Sasaki, T ^a   Buchanan, J A ^a   Kennedy, J L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; SERINE;

ANATOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DOPAMINERGIC SYSTEM; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; PHARMACOLOGY; PRIORITY JOURNAL; TWINS;

ANIMALIA;

EID: 15144354438     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-199800830-00005     Document Type: Article

References (45)

1. Austin LS, Lydiard B, Ballenger JC, Cohen BM, Larsia MT, Zealberg JJ et al. (1991). Dopamine blocking activity of clomipramine in patients with obsessive compulsive disorder. Biol Psychiatry 30:225-232.
2. Barr CL, Kidd KK (1993). Population frequencies of the A1 allele at the dopamine D2 receptor locus. Biol Psychiatry 34:204-209.
3. Baxter LR, Schwartz JM, Guze BH (1991). Brain imaging: toward a neuroanatomy of OCD. In: The Psychobiology of Obsessive Compulsive Disorder. Zohar J, Insel TR, Rasmussen S (editors). New York: Springer.
4. Billett EA, Richter MA, King N, Heils A, Lesch KP, Kennedy JL (1997). Obssesive-compulsive disorder, response to scrotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry 2:403-406.
5. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH (1996). Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet 12:81-84.
6. Catalano M, Sciuto G, Di Bella D, Novelli E, Nobile M, Bellodi L (1994). Lack of association between obsessive compulsive disorder and the dopamine D3 receptor gene: some preliminary considerations. Am J Med Genet 54:253-255.
7. Cichon S, Nothen MM, Erdmann J, Popping P (1994). Detection of four polymorphic sites in the human dopamine D1 receptor gene (DRD1). Hum Mol Genet 3:209.
8. Cohen DJ, Shaywitz BA, Caparulo B, Young JG, Bowers MB Jr (1978). Chronic, multiple tics of Gilles de la Tourette disease: CSF acid monoamine metabolism after probenecid administration
9. Cruz C, Camarena B, King N, Paez F, Sidenberg D, Fuente JR, Nicolini H (1997). Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients obsessive-compulsive disorder with tics. Neurosci Lett 231:1-4.
10. Di Bella D, Catalano M, Cichon S, Nothen MM (1996). Association study of a null mutation in the dopamine D4 receptor gene in Italian patients with obsessive-compulsive disorder, bipolar mood disorder and schizophrenia. Psychiatr Genet 6(3): 119-21.
11. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D et al. (1996). Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 12:78-80.
12. Gawin FH, Ellinwood EH Jr (1988). Cocaine and other stimulants. Actions, abuse and treament. N Engl J Med 318:1173-1182.
13. Ghaemi SN, Zarate CA Jr, Popli AP, Pillay SS, Cole JO (1995). Is there a relationship between clozapine and obsessive-compulsive disorder? A retrospective chart review. Comp Psychiatry 36:267-270.
14. Glantz SA (1992). Primer of Biostatistics: The Program (Version 3.0). New York: McGraw-Hill.
15. Golden GS (1974). Gilles de la Tourette's syndrome following methylphenidate administration. Dev Med Child Neurol 16:76-78.
16. Goodman WK, McDougle C, Price L, Riddle M, Pauls D, Leckman J (1990). Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry 51:36-43.
17. Grandy DK, Zhang Y, Civelli O (1993). PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 2(12):2197.
18. Insel TR (1992). Toward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry 49:739-744.
19. 311→Cys). Biochem Biophys Res Comm 196:1369-1375.
20. Kennedy JL, Billett EA, Macciardi FM, Verga M, Parsons TJ, Meltzer HY et al. (1995). Association study of dopamine D3 receptor gene and schizophrenia. Am J Med Genet (Neuropsychiatric Genetics) 60:558-562.
21. Kurlan R (1994). Tourette's Syndrome is part of a clinical spectrum that includes normal brain development. Arch Neurol 51:1145-1140.
22. Lahiri DK, Nurnberger JI Jr (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis. Nucleic Acids Res 19:5444.
23. Lahti RA, Conley R, Grubowski L, Tamminga CA (1995). Distribution of dopamine D2, D3 and D4 receptors in human post-mortem brain sections. Schizoph Res 15:63.
24. Lannfelt L, Sokoloff P, Martres M-P, Pilon C, Giros B, Jonsson E et al. (1992). Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 2:249-256.
25. Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK, Livak KJ (1993). A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 2:767-773.
26. Lipinski JF, Mallya G, Zimmerman P, Pope HG (1989). Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry 50:339-342.
27. Lowe TL, Cohen DJ, Detlor J, Kremenitzer MW, Shaywitz BA (1982). Stimulant medications precipitate Tourette's syndrome. J Am Med Assoc 247:1729-1731.
28. McDougle CJ, Goodman WK, Delgado PL, Price LH (1989).Pathophysiology of obsessive compulsive disorder (Letter). Am J Psychiatry 146:1350-1351.
29. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Herninger GR, Price LH (1994). Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 51:302-308.
30. Nee LE, Caine ED, Polinsky RJ, Eldridge R, Ebert MH (1980). Gilles de la Tourette Syndrome: clinical and family study of 50 cases. Ann Neurol 7:41-49.
31. Novelli E, Nobile M, Diaferia G, Sciuto G, Catalano, M (1994). A molecular investigation suggests no relationship between obsessive compulsive disorder and the dopamine D2 receptor. Neuropsychobiology 29:61-63.
32. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF (1995). A family study of obsessive compulsive disorder. Am J Psychiatry 152:76-84.
33. Pitman RK, Green RC, Jenike JA, Mesulam MM (1987). Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry 144:1166-1171.
34. Rapoport JL (1991). Recent advances in obsessive compulsive disorder. Neuropsychopharmacology 5:1-10.
35. Rasmussen SA (1993). Genetic studies of obsessive-compulsive disorder. Ann Clin Psychiatry 5:241-247.
36. Rauch SL, Jenike MA (1993). Neurobiological models of obsessive-compulsive disorder. Psychosomatics 34:20-32.
37. Riddle MA, Scahill L, King R, Hardin MT, Towbin KE, Ort SI et al. (1990). Obsessive-compulsive disorder in children and adolesecents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry 29:766-772.
38. Riddle MA, Leckman JF, Hardin MT, Anderson GM, Cohen DJ. (1988). Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome. Am J Psychiatry 145:1173-1174.
39. Satel SL, McDougle CJ (1991). Obsessions and compulsions associated with cocaine abuse (Letter). Am J Psychiatry 148:947.
40. Schilder P (1938). The organic background of obsessions and compulsions. Am J Psychiatry 94:1397-1414.
41. Schwartz J-C, Levesque D, Martres M-P, Sokoloff P (1993). Dopamine D3 receptor: basic and clinical aspects. Clin Neuropharmacol 16:295-314.
42. Shapiro AK, Shapiro E, Eisenkraft GJ (1983). Treatment of Gilles de la Tourette syndrome with pimozide. Am J Psychiatry 140:1183-1186.
43. Swedo SE, Rapoport JL, Cheslow DL, Leonard HL, Ayoub EM, Hosier DM, Wald ER (1989). High prevalence of obsessive compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 146:246-249.
44. Tarazi FI, Florijn WJ, Creese I (1995). Distinct localization and regulation of dopamine D3 receptors: autoradiographic studies. Schizophr Res 15:168.
45. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106.